Tidutamab (Anti-CD3 & SSTR2)
Tidutamab (Anti-CD3 & SSTR2) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). It can be used in neuroendocrine tumors (NETs) and small cell lung cancer (SCLC). MW :147.36 KD.
| Trivial name | XmAb-18087 |
| Catalog Number | A3170 |
| CAS# | 2148354-90-7 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/tidutamab-anti-cd3--sstr2.html |